India Preclinical Research Market to Grow at 11.5% CAGR by 2030

Overview of the India Preclinical Research Market: Key Statistics and Trends:

According to the latest report by MarkNtel Advisors, titled “India Preclinical Research Market By Model Type (Patient-Derived Organoid (PDO) model, Patient-Derived Xenograft (PDX) model), By Service (Bioanalysis and DMPK studies, [In vitro ADME, In-vivo PK], Toxicology testing, [GLP, Non-GLP], Compound management, [Process R&D, Custom synthesis, Others], Chemistry, [Medicinal chemistry, Computation chemistry], Safety Pharmacology Others), By End User (Biopharmaceutical Companies, Government and academic institutes, Medical device companies, Others), and Others, The India Preclinical Research Market size was valued at around USD 175 million in 2024 and is projected to reach USD 300 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 11.5% during the forecast period (2025-30). The report provides a thorough analysis of the market, covering competitor dynamics, regional insights, and a detailed breakdown of industry segments.

India Preclinical Research Market Growth and Scope:

Base Year: 2024

Forecast Period: 2025-30

Historical Data: 2020-23

CAGR (2025-2030): 11.5%

Request Free Sample Report (Exclusive Offer on this report): https://www.marknteladvisors.com/query/request-sample/india-pre-clinical-research-market.html

India Preclinical Research Market Opportunity:

Emergence of Targeted Therapies & Personalized Medicine – The emerging field of precision medicine and targeted therapies holds vast opportunities in the preclinical research market of India. Rapid growth can be seen in precession medicine specifically in oncology and immunology. It focuses on customized treatment based on the patient’s profile requiring intense preclinical research. Several international pharmaceutical companies like; Pfizer, Boehringer Ingelheim, AstraZeneca, and others are increasingly collaborating with Indian CROs for the preclinical stages, with a focus on target therapies, especially in oncology providing numerous opportunities for market growth.

In addition, the growing expertise of India in areas of molecular biology and genetic research can place India at the pinnacle of validation of biomarkers and identification of genetic targets that are crucial for precision medicine ultimately bringing more investments in the market.

A Comprehensive Analysis of Leading Companies of India Preclinical Research Market by MarkNtel Advisors:

Syngene International Limited
Dabur Research
JSS Medical Research
Jubilant Biosys Ltd.
Sugen Life Sciences
Eurofins Advinus
GVRP
Veeda Clinical Research Limited
Axis Clinicals
Syneos Health
Ethicare-cro
Liveon Biolabs Pvt. Ltd.
IQVIA Inc.
Bioneeds
TheraIndx Lifesciences Pvt. Ltd.
Abiogenesis Clinpharm
Accutest Global
Asiatic Clinical Research
Bio Reliance Corporation
Cliniminds
Hi Tech Bio Laboratories
GVK Biosciences
Others

Key India Preclinical Research Market Segmentation:

Explore Our Comprehensive Study: https://www.marknteladvisors.com/research-library/india-pre-clinical-research-market.html

-By Model Type

Patient-Derived Organoid (PDO) Model
Patient-Derived Xenograft (PDX) Model

Out of them, the Patient-Derived Organoid (PDO) Model leads the market with more than 50% of the market share.

-By End User

Biopharmaceutical companies
Government and academic institutes
Medical device companies
Others

Out of them, biopharmaceutical companies lead the India Preclinical Research Market. It holds more than 40% of the market share.

Geographical Analysis

-By Region

North
East
West
South

Out of them, the South region dominates the India Preclinical Research Market. This region holds more than 35% of the market share.

Key Reports Highlights:

Market Dimensions & Projections
Pricing Evaluation,
Recent Strategic Moves by Companies,
Primary Stakeholders,
Analysis of Import and Export Trends,
Competitive Landscape Assessment,
Emerging Opportunities,
Market Trends and Indicators

Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/india-pre-clinical-research-market.html

“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”

Key Advantages of the Report by MarkNtel Advisors:

Accurate Revenue Projections: The report provides precise revenue estimates for the market and its key sub segments, benefiting both market leaders and new entrants.
Strategic Insights for Stakeholders: By understanding the competitive landscape, stakeholders can strategically position their businesses and develop effective go-to-market strategies.
Comprehensive Market Dynamics Analysis: The report offers valuable insights into the key drivers, restraints, challenges, and opportunities within the market, helping stakeholders make well-informed decisions.

Note: If you need additional information not included in the report, we can customize it to suit your requirements.

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 11.50+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

More Research Studies:

The Middle East Zero Trust Security Market is projected to grow at a CAGR of 8.14. 11.54%, reaching USD4. 11.54 Billion by 2028, from USD 2.4. 11.541 Billion in 2024. 11.54.
Unveil the flourishing Global Behavioral Analytics Market, valued at USD8 Billion in 2023. Projected to surge at a CAGR of over 4. 11.540% from 2023 to 2028. (Top Companies - IBM Corporation, Microsoft Corporation, Splunk Inc., Varonis Systems Inc., Exabeam Inc., Niara Inc., SAP SE, and Oracle Corporation)
Global Hypersonic Technology Market size was valued at USD2 Billion in 2023 & is estimated to grow at a CAGR of around 11.5.32% during the forecast period 2023-28, the growing focus on naval superiority & anti-ship capabilities is creating a notable growth opportunity for the Market.
The Global Artificial Intelligence in Neurology Market is expacted to reach USD 11.548 million in 2023 and is estimated to grow at a CAGR of about 4. 11.546% during the forecast period 2023-28.